PubMed Health⌕ Search

PubMed · 12873665

Prostate localization using transabdominal ultrasound imaging.

Abstract

PURPOSE: Adding margin around a target is done in an attempt to ensure complete coverage of the target. The B-mode acquisition and targeting (BAT) system allows ultrasound imaging of the prostate in patients with a full bladder. This provides a setup tool for patients with localized prostate cancer that takes into account real-time prostate position and may make it possible to decrease tumor margins. Prostate localization using the conventional setup verification method and daily isocenter shifts recommended by the ultrasound imaging system (BAT) were compared and analyzed. METHODS AND MATERIALS: Daily treatment isocenter shifts for patients with localized adenocarcinoma of the prostate, obtained from two different imaging modalities, electronic portal imaging (EPI) and BAT, were calculated. We studied the difference in patient setup error calculated using BAT contour alignment and measured from EPI; the reproducibility of BAT contour alignment; intrafraction prostate motion; and how the BAT imaging procedure itself affected the prostate position. Prostate motion relative to its position during simulation was calculated by subtracting the EPI-measured isocenter shifts from the corresponding BAT-defined isocenter shifts. BAT reproducibility was measured by taking a verification BAT image after the patient was moved according to the initial BAT-defined isocenter shifts. Intrafraction prostate motion was measured by repeating BAT imaging at the end of a treatment fraction. The BAT imaging effect on prostate position was studied by examining the effect of suprapubic pressure on seed position in patients after a seed implant. RESULTS: The mean BAT isocenter shifts for prostate motion were 0.32 +/- 0.46 cm in the lateral, 0.31 +/- 0.73 cm in the superoinferior, and 0.32 +/- 0.56 cm in the AP directions. Isocenter shifts obtained from EPI measurements were significantly smaller, with a mean of 0.05 +/- 0.24 cm in the lateral, 0.01 +/- 0.11 cm in the superoinferior and -0.11 +/- 0.29 cm in the AP directions. This larger shift seen by BAT was due to prostate motion. For BAT reproducibility, the results showed that for BAT verification images, 90% of the lateral shifts were <0.2 cm, 93% of the superoinferior shifts were <0.3 cm, and 83% of the AP shifts were <0.2 cm. The mean isocenter shift (intrafraction localization error) during patient treatment fraction was 0.02 +/- 0.28 cm in the lateral, 0.04 +/- 0.48 cm in the superoinferior, and 0.0 +/- 0.32 cm in the AP direction. The BAT procedure itself induced an average motion of 1 mm in the AP and superoinferior directions. CONCLUSIONS: Prostate patient setup verification on the basis of bony anatomy position does not reflect the actual prostate position. BAT ultrasound target alignment provides a real-time prostate localization system that may make it possible to measure prostate position variations and reduce margins.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Frieda Trichter, Ronald D Ennis. 2003-08-01. Prostate localization using transabdominal ultrasound imaging.. https://doi.org/10.1016/s0360-3016(03)00269-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗